ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Generation Uranium Inc

Generation Uranium Inc (GEN)

0,075
-0,01
( -11,76% )
Aktualisiert: 20:04:47

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,075
Gebot
0,08
Fragen
0,095
Volumen
118.961
0,075 Tagesbereich 0,085
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,085
Handelsbeginn
0,085
Letzte Trade
21000
@
0.075
Letzter Handelszeitpunkt
19:55:55
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
24.596.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,40
Gewinn pro Aktie (EPS)
-0,03
Erlöse
-
Nettogewinn
-717k

Über Generation Uranium Inc

Sektor
Gold Ores
Branche
Unit Inv Tr, Closed-end Mgmt
Hauptsitz
Richmond, British Columbia, Can
Gegründet
2022
Generation Uranium Inc is listed in the Gold Ores sector of the TSX Venture Börse with ticker GEN. The last closing price for Generation Uranium was $0,09. Over the last year, Generation Uranium shares have traded in a share price range of $ 0,00 to $ 0,00.

Generation Uranium currently has 24.596.000 shares in issue. The market capitalisation of Generation Uranium is $2,09 million. Generation Uranium has a price to earnings ratio (PE ratio) of -2.40.

GEN Neueste Nachrichten

Emerging Markets Report: Piece of Cake

ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Today’s featured company is a simple story. It’s a uranium play. For those of you who have dabbled in the markets for any length of time you may...

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product Patient enrolment in clinical trial expected...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune area - pemphigus vulgaris Patient...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release     Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation PBD-based warhead technology 50:50 partnership ...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct clinical development under a license from Roche...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market effective today ADR ticker symbol GMXAY...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of 9.3 months compared to chlorambucil alone No...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net sales increased 65% over Q1...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GEN - Frequently Asked Questions (FAQ)

What is the current Generation Uranium share price?
The current share price of Generation Uranium is $ 0,075
How many Generation Uranium shares are in issue?
Generation Uranium has 24.596.000 shares in issue
What is the market cap of Generation Uranium?
The market capitalisation of Generation Uranium is CAD 2,09M
What is the 1 year trading range for Generation Uranium share price?
Generation Uranium has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Generation Uranium?
The price to earnings ratio of Generation Uranium is -2,4
What is the reporting currency for Generation Uranium?
Generation Uranium reports financial results in CAD
What is the latest annual profit for Generation Uranium?
The latest annual profit of Generation Uranium is CAD -717k
What is the registered address of Generation Uranium?
The registered address for Generation Uranium is PO BOX 31880, STEVESTON VILLAGE, RICHMOND, BRITISH COLUMBIA, V7E 0B5
What is the Generation Uranium website address?
The website address for Generation Uranium is www.generationuranium.com
Which industry sector does Generation Uranium operate in?
Generation Uranium operates in the UNIT INV TR, CLOSED-END MGMT sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MPTH.HMapath Capital Corp
$ 0,035
(250,00%)
1.000
ETUE2gold Inc
$ 0,01
(100,00%)
8,55k
MAHMarksmen Energy Inc
$ 0,01
(100,00%)
1.000
CMILCapella Minerals Ltd
$ 0,01
(100,00%)
22k
ALTAlturas Minerals Corp
$ 0,01
(100,00%)
1,1k
CPERCoppercorp Resources Inc
$ 0,11
(-52,17%)
2,93M
ICRSIcarus Capital Corp
$ 0,015
(-50,00%)
27k
SSESilver Spruce Resources Inc
$ 0,005
(-50,00%)
17k
GNFIGenifi Inc
$ 0,005
(-50,00%)
12k
NICKNickelex Resource Corporation
$ 0,005
(-50,00%)
270,3k
TAUCommon Stock
$ 0,55
(-5,17%)
4,43M
QNCQuantum Emotion Corp
$ 0,39
(-11,36%)
4,24M
GPUSAlset AI Ventures Inc
$ 0,10
(-9,09%)
3,46M
MATEBlockmate Ventures Inc
$ 0,205
(-8,89%)
2,96M
CPERCoppercorp Resources Inc
$ 0,11
(-52,17%)
2,93M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock